The attachment protein “spike” of the new coronavirus SARS-CoV-2 uses the same cellular attachment factor (ACE2) as SARS-CoV and uses the cellular protease TMPRSS2 for its activation. Existing, clinically approved drugs directed against TMPRSS2 inhibit SARS-CoV-2 infection of lung cells. Illustration: Markus Hoffmann
Göttingen infection researchers identify potential drug
Viruses must enter cells of the human body to cause disease. For this, they attach to suitable cells and inject their genetic information into these cells. Infection biologists from the German Primate Center – Leibniz Institute for Primate Research in Göttingen, together with colleagues at Charité – Universitätsmedizin Berlin, have investigated how the novel coronavirus SARS-CoV-2 penetrates cells. They have identified a cellular enzyme that is essential for viral entry into lung cells: the protease TMPRSS2. A clinically proven drug known to be active against TMPRSS2 was found to block SARS-CoV-2 infection and might constitute a novel treatment option (Cell).
Several coronaviruses circulate worldwide and constantly infect humans, which normally caused only mild respiratory disease. Currently, however, we are witnessing a worldwide spread of a new coronavirus with more than 90,000 confirmed cases and over 3,000 deaths. The new virus has been named SARS coronavirus-2 and has been transmitted from animals to humans. It causes a respiratory disease called COVID-19 that may take a severe course. The SARS coronavirus-2 has been spreading since December 2019 and is closely related to the SARS coronavirus that caused the SARS pandemic in 2002/2003. No vaccines or drugs are currently available to combat these viruses.
Stopping virus spread
A team of scientists led by infection biologists from the German Primate Centre and including researchers from Charité, the University of Veterinary Medicine Hannover Foundation, the BG-Unfallklinik Murnau, the LMU Munich, the Robert Koch Institute and the German Center for Infection Research, wanted to find out how the new coronavirus SARS-CoV-2 enters host cells and how this process can be blocked. The researchers identified a cellular protein that is important for the entry of SARS-CoV-2 into lung cells. “Our results show that SARS-CoV-2 requires the protease TMPRSS2, which is present in the human body, to enter cells,” says Stefan Pöhlmann, head of the Infection Biology Unit at the German Primate Center. “This protease is a potential target for therapeutic intervention.”
Since it is known that the drug camostat mesilate inhibits the protease TMPRSS2, the researchers have investigated whether it can also prevent infection with SARS-CoV-2. “We have tested SARS-CoV-2 isolated from a patient and found that camostat mesilate blocks entry of the virus into lung cells,” says Markus Hoffmann, the lead author of the study. Camostat mesilate is a drug approved in Japan for use in pancreatic inflammation. “Our results suggest that camostat mesilate might also protect against COVID-19,” says Markus Hoffmann. “This should be investigated in clinical trials.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Rising COVID-19 Numbers Show UK Has a Serious Problem: Health Ministeron October 7, 2020 at 3:08 am
LONDON (Reuters) - Britain's rising numbers of COVID-19 infections and an increase in people being hospitalised with the disease demonstrate that there is a serious problem, health minister Matt ...
- Column: Why are Trump and Republicans the ones getting COVID-19? Must be a liberal conspiracy.on October 7, 2020 at 3:06 am
I don’t mean to sound conspiratorial, but I think godless DEMONcrats infected President Trump, Republican senators and other leaders with COVID-19.
- Should a condo association prohibit pool use because of covid-19?on October 7, 2020 at 3:03 am
How do I get our homeowners association board to open up our building’s three pools, all of which have been closed since March due to the pandemic? The board members say they are concerned that if ...
- Czech COVID-19 Cases Rising at Fastest Rate in Europeon October 7, 2020 at 2:46 am
The Czech Republic reported a record 4,457 new coronavirus cases in a single day, Health Ministry data showed on Wednesday, as a spike in infections over the past month is now rising at Europe's ...
- Pence, Harris to debate in sole VP matchup of 2020 amid heightened COVID-19 concernson October 7, 2020 at 2:41 am
Vice President Mike Pence and Sen. Kamala Harris of California will debate in Salt Lake City on Tuesday in the sole matchup between the 2020 vice presidential candidates.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Daewoong pancreatitis drug tested as Covid-19 treatmenton September 14, 2020 at 10:57 am
Daewoong’s Foistar tablets, made of camostat mesilate, will be tested on 180 coronavirus patients with light or moderate symptoms, for 40 days. The trial will be conducted by researchers at the ...
- Could an existing drug help against the new coronavirus?on August 11, 2020 at 2:31 am
A German consortium led by the German Primate Center in Göttingen is also planning clinical trials with camostat mesilate. This active ingredient, which is approved in Japan for the treatment of ...